Pfizer’s COVID-19 vaccine has become one of the most widely used inoculation in the United States and Europe, and its sales has outpaced that of its rivals.
Pfizer expects $29B in COVID-19 vaccine sales next year
Pfizer’s COVID-19 vaccine has become one of the most widely used inoculation in the United States and Europe, and its sales has outpaced that of its rivals.